Logo image of LUNG

PULMONX CORP (LUNG) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:LUNG - US7458481014 - Common Stock

2.3 USD
+0.09 (+4.07%)
Last: 1/2/2026, 8:00:01 PM
2.26 USD
-0.04 (-1.74%)
Pre-Market: 1/5/2026, 8:08:50 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LUNG revenue by date.LUNG revenue by date.
53.66M
10.82%
68.675M
27.98%
83.789M
22.01%
91.506M
9.21%
96.111M
5.03%
116.88M
21.61%
159.7M
36.64%
278.94M
74.66%
374.45M
34.24%
649.93M
73.57%
755.79M
16.29%
EBITDA
YoY % growth
LUNG ebitda by date.LUNG ebitda by date.
-57.13M
-23.05%
-60.387M
-5.70%
-54.511M
9.73%
-37.233M
31.70%
-32.266M
13.34%
-19.477M
39.64%
-37.434M
-92.20%
N/AN/AN/AN/A
EBIT
YoY % growth
LUNG ebit by date.LUNG ebit by date.
-58.64M
-23.97%
-61.935M
-5.62%
-56.004M
9.58%
-60.613M
-8.23%
-56.65M
6.54%
-40.817M
27.95%
-7.875M
80.71%
75.462M
1,058.28%
143.78M
90.53%
361.02M
151.09%
437.07M
21.07%
Operating Margin
LUNG operating margin by date.LUNG operating margin by date.
-109.28%-90.19%-66.84%-66.24%-58.94%-34.92%-4.93%27.05%38.40%55.55%57.83%
EPS
YoY % growth
LUNG eps by date.LUNG eps by date.
-1.59
-21.37%
-1.60
-0.63%
-1.40
12.50%
-1.50
-7.10%
-1.36
9.12%
-1.05
22.90%
-0.21
80.26%
1.56
850.12%
2.85
82.95%
6.86
141.22%
7.81
13.82%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.40
-21.16%
-0.35
3.67%
-0.34
10.88%
-0.34
-1.40%
-0.34
15.82%
-0.24
29.41%
-0.24
27.71%
-0.24
28.99%
-0.23
30.30%
Revenue
Q2Q % growth
22.163M
-6.74%
22.593M
0.24%
23.246M
-2.57%
23.837M
10.86%
24.628M
11.12%
26.224M
16.07%
28.203M
21.32%
27.203M
14.12%
28.611M
16.17%
EBITDA
Q2Q % growth
-11.307M
5.17%
-7.73M
45.89%
-7.019M
50.66%
-8.897M
34.43%
-9.292M
17.82%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-15.984M
-19.14%
-14.163M
2.75%
-13.838M
6.53%
-15.03M
-4.42%
-14.585M
8.75%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.34
5.56%
-0.430.0920.32%
Q2 2025
Q2Q % growth
-0.38
-8.57%
-0.380.000.21%
Q1 2025
Q2Q % growth
-0.36 -0.380.025.30%
Q4 2024
Q2Q % growth
-0.33
8.33%
-0.460.1327.70%
Q3 2024
Q2Q % growth
-0.36
7.69%
-0.460.1021.31%
Q2 2024
Q2Q % growth
-0.35
18.60%
-0.430.0819.29%
Q1 2024
Q2Q % growth
-0.36
14.29%
-0.470.1123.51%
Q4 2023
Q2Q % growth
-0.36
5.26%
-0.420.0613.32%
Q3 2023
Q2Q % growth
-0.39
-2.63%
-0.440.0510.63%
Q2 2023
Q2Q % growth
-0.43
-7.50%
-0.450.023.49%
Q1 2023
Q2Q % growth
-0.42
2.33%
-0.450.036.42%
Q4 2022
Q2Q % growth
-0.38
-8.57%
-0.420.0410.51%
Q3 2022
Q2Q % growth
-0.38
-35.71%
-0.400.026.06%
Q2 2022
Q2Q % growth
-0.40
-17.65%
-0.420.024.32%
Q1 2022
Q2Q % growth
-0.43
-26.47%
-0.38-0.05-13.59%
Q4 2021
Q2Q % growth
-0.35
-29.63%
-0.370.024.77%
Q3 2021
Q2Q % growth
-0.28
87.61%
-0.380.1026.23%
Q2 2021
Q2Q % growth
-0.34 -0.380.0410.36%
Q1 2021
Q2Q % growth
-0.34 -0.390.0511.88%
Q4 2020
Q2Q % growth
-0.27 -0.280.014.78%
Q3 2020
Q2Q % growth
-2.26 -4.412.1548.71%
LUNG Yearly EPS VS EstimatesLUNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
21.502M
5.47%
21.286M216K1.01%
Q2 2025
Q2Q % growth
23.859M
14.80%
23.938M-79K-0.33%
Q1 2025
Q2Q % growth
22.538M
19.54%
22.474M64K0.28%
Q4 2024
Q2Q % growth
23.765M
23.28%
22.736M1.029M4.53%
Q3 2024
Q2Q % growth
20.387M
15.39%
20.694M-307K-1.48%
Q2 2024
Q2Q % growth
20.783M
20.87%
20.536M247K1.20%
Q1 2024
Q2Q % growth
18.854M
29.71%
18.251M603K3.30%
Q4 2023
Q2Q % growth
19.278M
24.94%
18.639M639K3.43%
Q3 2023
Q2Q % growth
17.668M
30.87%
16.714M954K5.71%
Q2 2023
Q2Q % growth
17.194M
23.25%
16.178M1.016M6.28%
Q1 2023
Q2Q % growth
14.535M
34.71%
13.764M771K5.60%
Q4 2022
Q2Q % growth
15.43M
12.55%
14.263M1.167M8.18%
Q3 2022
Q2Q % growth
13.5M
1.81%
15.215M-1.715M-11.27%
Q2 2022
Q2Q % growth
13.95M
14.34%
14.003M-53K-0.38%
Q1 2022
Q2Q % growth
10.79M
16.77%
9.446M1.344M14.23%
Q4 2021
Q2Q % growth
13.71M
39.47%
14.527M-817K-5.62%
Q3 2021
Q2Q % growth
13.26M
24.98%
13.441M-181K-1.35%
Q2 2021
Q2Q % growth
12.2M
232.43%
10.718M1.482M13.83%
Q1 2021
Q2Q % growth
9.24M
7.19%
8.3M940K11.33%
Q4 2020
Q2Q % growth
9.83M 8.984M846K9.42%
Q3 2020
Q2Q % growth
10.61M 8.534M2.076M24.33%
LUNG Yearly Revenue VS EstimatesLUNG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -0.08% 0% 4.96%
Revenue0% -7.25% 0% -0.99%